Literature DB >> 7855343

Pathways of nodal metastasis from pelvic tumors: CT demonstration.

J M Park1, C Charnsangavej, K Yoshimitsu, D H Herron, T J Robinson, S Wallace.   

Abstract

Although the normal pathways of lymphatic drainage from the pelvic organs have been well described in the anatomy literature, the pathways of nodal metastasis from individual pelvic neoplasms are not well illustrated in the imaging literature. The authors retrospectively reviewed computed tomographic scans of the abdomen and pelvis in patients with various pelvic neoplasms, including those of the ovary, testis, prostate, cervix, bladder, anorectum, and other sites, to define the pathways of nodal metastasis. In most patients, pathways of nodal metastasis correlated well with the normal lymphatic pathways described in the anatomy literature, including the superficial inguinal pathway; the anterior, lateral, hypogastric, and presacral routes of the pelvic pathway; and the paraaortic pathway. However, there also were various uncommon pathways of nodal metastasis, such as metastasis along the gonadal vessels, mesenteric and mesocolic nodes, posterior iliac crest nodes, and inferior phrenic nodes. Understanding these common and uncommon lymphatic pathways of metastasis will help radiologists detect disease spread from pelvic tumors.

Entities:  

Mesh:

Year:  1994        PMID: 7855343     DOI: 10.1148/radiographics.14.6.7855343

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  17 in total

1.  Cervical cancer: MR imaging findings before, during, and after radiation therapy.

Authors:  Gulgun Engin
Journal:  Eur Radiol       Date:  2005-06-14       Impact factor: 5.315

2.  Posterior iliac crest lymph node metastasis from ovarian cancer 15 years after surgery: a mimicker of primary retroperitoneal tumor.

Authors:  Makoto Shinoto; Kousei Ishigami; Kengo Yoshimitsu; Satoshi Amada; Hiroshi Honda
Journal:  Eur Radiol       Date:  2006-03-17       Impact factor: 5.315

Review 3.  Sentinel node evaluation in prostate cancer.

Authors:  Ramkishen Narayanan; Timothy G Wilson
Journal:  Clin Exp Metastasis       Date:  2018-09-05       Impact factor: 5.150

4.  Infratemporal fossa metastasis from carcinoma of the uterine cervix.

Authors:  Ioannis Dimitrakopoulos; Aris Ntomouchtsis; Fotis Iordanidis
Journal:  Oral Maxillofac Surg       Date:  2011-06

5.  Patterns of failure after radical prostatectomy in prostate cancer - implications for radiation therapy planning after 68Ga-PSMA-PET imaging.

Authors:  Kilian Schiller; K Sauter; S Dewes; M Eiber; T Maurer; J Gschwend; S E Combs; G Habl
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-06-23       Impact factor: 9.236

Review 6.  Recurrent uterine cervical carcinoma: spectrum of imaging findings.

Authors:  J I Choi; S H Kim; C K Seong; J S Sim; H J Lee; K H Do
Journal:  Korean J Radiol       Date:  2000 Oct-Dec       Impact factor: 3.500

7.  Uterine cervical cancer metastases to mediastinal lymph nodes diagnosed by endoscopic ultrasound-guided fine needle aspiration.

Authors:  Somashekar G Krishna; Yezaz A Ghouri; Rei Suzuki; Manoop S Bhutani
Journal:  Endosc Ultrasound       Date:  2013-10       Impact factor: 5.628

Review 8.  Imaging of abdominal nodal spread in malignant disease.

Authors:  S Delorme; G van Kaick
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

Review 9.  Implications of the new FIGO staging and the role of imaging in cervical cancer.

Authors:  Aki Kido; Yuji Nakamoto
Journal:  Br J Radiol       Date:  2021-05-14       Impact factor: 3.629

10.  Combined PET and whole-tissue imaging of lymphatic-targeting vaccines in non-human primates.

Authors:  Jacob T Martin; Brittany L Hartwell; Sidath C Kumarapperuma; Mariane B Melo; Diane G Carnathan; Benjamin J Cossette; Josetta Adams; Siqi Gong; Wei Zhang; Talar Tokatlian; Sergey Menis; Torben Schiffner; Crystal G Franklin; Beth Goins; Peter T Fox; Guido Silvestri; William R Schief; Ruth M Ruprecht; Darrell J Irvine
Journal:  Biomaterials       Date:  2021-05-14       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.